Staphylococcus Lugdunensis Endocarditis and Cerebrovascular Accident: A Systemic Review of Risk Factors and Clinical outcome
- PMID: 29900089
- PMCID: PMC5997432
- DOI: 10.7759/cureus.2469
Staphylococcus Lugdunensis Endocarditis and Cerebrovascular Accident: A Systemic Review of Risk Factors and Clinical outcome
Abstract
Infective endocarditis (IE) secondary to Staphylococcus lugdunensis has been increasingly recognized since 1988. IE-related thromboembolism represents an associated complication of the disease and carries a dismal prognosis. However, the incidence of cerebrovascular accident secondary to S. lugdunensis IE is relatively uncommon and its treatment has not been clearly elucidated yet. We performed an extensive literature search using Pubmed, Medline, Scopus, and Google Scholar to identify the articles using the following keywords: 'Staphylococcus lugdunensis', 'infective endocarditis', 'stroke', and 'cerebrovascular accident.' Patient characteristics, risk factors, severity of neurological deficit, echocardiographic findings, medical management, required surgical intervention, complications and mortality rate were reviewed in detail. Eighteen cases (mean age of 47.8 years, 55% male) from 17 publications with S. lugdunensis-related cerebrovascular accident (CVA) were identified. Of these, 16 (87%) cases were left-sided endocarditis and 10 (61%) cases experienced right-sided neurological deficit. The source of infection was documented in eight cases (50%) in which four cases (50%) were related to groin-related procedures and the mitral valve (52.5%) was mostly infected followed by aortic valve (37%). Surgical valve replacement was done in 61% of patients and overall mortality rate was 22%. S. lugdunensis endocarditis is associated with high mortality and morbidity, including a higher prevalence of CVA. Early disease identification with aggressive intervention is crucial for better outcomes.
Keywords: cardiology; cerebrovascular accident; endocarditis; infectious endocarditis; staphylococcus lugdunensis.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Historical aspects of infective endocarditis (Article in English, Portuguese) Grinberg M, Solimene MC. Rev Assoc Med Bras. 2011;57:228–233. - PubMed
-
- Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. Duval X, Delahaye F, Alla F, et al. J Am Coll Cardiol. 2012;59:1968–1976. - PubMed
-
- Staphylococcus lugdunensis sp. nov. and Staphylococcus schleiferi sp. nov., two species from human clinical specimens. Freney J, Brun Y, Bes M, et al. Int J Syst Evol Microbiol. 1988;38:168–172.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources